Countries North America

Verily and Kyverna Collaborate to Advance Cell Therapy for Autoimmune Diseases

Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company engineering a new clas...

 September 08, 2023 | News

Paige Partners with Microsoft to Create World's Largest Cancer-Fighting AI Model

Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images ...

 September 08, 2023 | News

Biocon Biologics Expands Global Presence, Completes Viatris Biosimilars Integration in North America Ahead of Schedule.

To further strengthen its leadership position in the global biosimilars industry and provide complete end-to-end capabilities to patients and customers, Bi...

 September 07, 2023 | News

Thyme Care Secures $60M Series B to Scale Cancer Care Beyond the Clinic

  Oncology care innovator streamlines a notoriously fragmented healthcare system, reducing gaps and barriers to care for chronically under supp...

 September 04, 2023 | News

Oracle Joins White House CancerX Initiative to Aid in the Fight Against Cancer

Oracle has been recognized as a founding member of CancerX. The public-private partnership was formed to drive innovations that can help reduce deaths...

 August 23, 2023 | News

Verily and OneOncology Announce Collaboration to Advance Cancer Research

Verily, an Alphabet precision health technology company, and OneOncology, the national platform for independent oncology practices, have established a stra...

 August 17, 2023 | News

OnCusp Therapeutics Gets FDA Nod for Phase 1 Trial of CUSP06 in Ovarian & Solid Tumors

"We are delighted to announce the IND approval for our flagship program, CUSP06, which has demonstrated excellent anti-tumor efficacy across diverse in&nbs...

 August 16, 2023 | News

Gates Foundation Picks 50 Projects for Equitable AI Access in Global Health

Following an overwhelming response to its most recent Grand Challenges request for proposals, the Bill & Melinda Gates Foundation today announced a gro...

 August 11, 2023 | News

Proteintech Accelerates Growth with Expansions in the US and China

Proteintech, the benchmark in antibodies and life science solutions, recently expanded at its US headquarters in Rosemont, IL, opened up a new office in Sh...

 August 07, 2023 | News

Ascentage Pharma Gets FDA Clearance for Global Phase III Trial of Lisaftoclax in CLL/SLL Patients

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related...

 August 07, 2023 | News

BioPharma America | Elevating Insights, Enabling Progress: Navigating BioPharma Excellence at Your Fingertips

Unveiling the Future of Pharma and Biotech: Explore Insights, Innovations, and Breakthroughs on BioPharma America – Your Premier Media Destination fo...

 August 05, 2023 | News

US FDA Grants Orphan Drug Status to ABM-1310 for BRAF V600 Glioblastoma

Orphan Drug Designation is a significant recognition bestowed by the FDA to the drugs used in the treatment of rare diseases. This designation intends to e...

 August 03, 2023 | News

FDA Clears Terumo's Reveos® Automated Whole Blood Processing System for U.S. Commercial Use

Terumo Blood and Cell Technologies (Terumo BCT) announces U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing ...

 August 02, 2023 | News

Lupin Pharmaceuticals Recalls 2 Lots of TydemyTM Due to OOS Results

Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0....

 July 31, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close